Solid Organ Transplant Complications

  • Print

SOT has become an effective life-saving therapy for patients with established organ failure. For many organs, 1-year survival rates are above 90%.1 Every organ transplant requires a delicate balance to prevent rejection and infection. The relationship between infection and rejection is closely intertwined and can be a vicious cycle. Monitoring for immune system related complications in advance of clinical symptoms can provide successful intervention to prevent rejection.

When your SOT patients face complex complications, depend on Viracor Eurofins, your source for specialized testing options with exceptional service.




References
1. OPTN Data as of November 29, 2013 (HTTP://OPTN.transplant.hrsa.gov)

ImmuKnow® is FDA cleared for the following Intended Use: Detection of cell-mediated immune response in populations undergoing immunosuppressive therapy for organ transplant. Product Insert 2015. Viracor Eurofins, Lee’s Summit, MO.